Insulet (PODD)
(Delayed Data from NSDQ)
$204.42 USD
+11.84 (6.15%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $202.65 -1.77 (-0.87%) 7:48 PM ET
3-Hold of 5 3
D Value B Growth F Momentum C VGM
Price, Consensus and EPS Surprise
PODD 204.42 +11.84(6.15%)
Will PODD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PODD based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for PODD
Insulet's Omnipod 5 Wins FDA Approval for Type 2 Diabetes
Illumina (ILMN) Beats on Q2 Earnings, Lowers 2024 Sales View
PODD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Insulet (PODD) Q2 Earnings Miss Estimates, '24 Sales View Raised
Insulet (PODD) Reports Q2 Earnings: What Key Metrics Have to Say
Insulet (PODD) Q2 Earnings Miss Estimates
Other News for PODD
Insulet Stock Buy Rating: FDA Approval Expands Market Reach for Omnipod 5
What's Driving Insulet Corp's Surprising 12% Stock Rally?
Early notable gainers among liquid option names on August 28th
Insulet FDA approval comes early with broad label, says TD Cowen
Biggest stock movers today: PODD, HIMS, PARA, and more